Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $1.37 billion. The enterprise value is $915.74 million.
| Market Cap | 1.37B |
| Enterprise Value | 915.74M |
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 220.02 million shares outstanding. The number of shares has increased by 29.29% in one year.
| Current Share Class | 220.02M |
| Shares Outstanding | 220.02M |
| Shares Change (YoY) | +29.29% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 1.24% |
| Owned by Institutions (%) | 81.34% |
| Float | 185.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27.12 |
| Forward PS | 19.25 |
| PB Ratio | 3.10 |
| P/TBV Ratio | 3.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.12, with a Debt / Equity ratio of 0.18.
| Current Ratio | 9.12 |
| Quick Ratio | 8.92 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.59 |
Financial Efficiency
Return on equity (ROE) is -93.48% and return on invested capital (ROIC) is -50.09%.
| Return on Equity (ROE) | -93.48% |
| Return on Assets (ROA) | -42.19% |
| Return on Invested Capital (ROIC) | -50.09% |
| Return on Capital Employed (ROCE) | -63.22% |
| Weighted Average Cost of Capital (WACC) | 10.99% |
| Revenue Per Employee | $155,028 |
| Profits Per Employee | -$1.01M |
| Employee Count | 325 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 65.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.95% in the last 52 weeks. The beta is 1.22, so OCUL's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -45.95% |
| 50-Day Moving Average | 7.99 |
| 200-Day Moving Average | 8.91 |
| Relative Strength Index (RSI) | 37.62 |
| Average Volume (20 Days) | 2,771,483 |
Short Selling Information
The latest short interest is 29.00 million, so 13.18% of the outstanding shares have been sold short.
| Short Interest | 29.00M |
| Short Previous Month | 28.76M |
| Short % of Shares Out | 13.18% |
| Short % of Float | 15.67% |
| Short Ratio (days to cover) | 8.76 |
Income Statement
In the last 12 months, OCUL had revenue of $50.38 million and -$326.81 million in losses. Loss per share was -$1.46.
| Revenue | 50.38M |
| Gross Profit | -201.94M |
| Operating Income | -343.07M |
| Pretax Income | -326.81M |
| Net Income | -326.81M |
| EBITDA | -336.26M |
| EBIT | -343.07M |
| Loss Per Share | -$1.46 |
Balance Sheet
The company has $530.61 million in cash and $80.01 million in debt, with a net cash position of $450.60 million or $2.05 per share.
| Cash & Cash Equivalents | 530.61M |
| Total Debt | 80.01M |
| Net Cash | 450.60M |
| Net Cash Per Share | $2.05 |
| Equity (Book Value) | 440.95M |
| Book Value Per Share | 2.01 |
| Working Capital | 511.58M |
Cash Flow
In the last 12 months, operating cash flow was -$253.14 million and capital expenditures -$13.90 million, giving a free cash flow of -$267.04 million.
| Operating Cash Flow | -253.14M |
| Capital Expenditures | -13.90M |
| Depreciation & Amortization | 6.81M |
| Net Borrowing | n/a |
| Free Cash Flow | -267.04M |
| FCF Per Share | -$1.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | -680.91% |
| Pretax Margin | -648.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -29.29% |
| Shareholder Yield | n/a |
| Earnings Yield | -23.49% |
| FCF Yield | -19.54% |
Analyst Forecast
The average price target for OCUL is $25.73, which is 314.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.73 |
| Price Target Difference | 314.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 67.27% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 3.94 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.94 |
| Piotroski F-Score | 2 |